AI-generated summary
This selective review examined studies of exogenous melatonin, light therapy, sleep deprivation and melatonin receptor agonists for depression. The authors report antidepressant effects for bright light therapy, especially in seasonal affective disorder, and for sleep deprivation, though that effect is time limited. They state that the role of melatonin as an antidepressant has yet to be demonstrated.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a selective review and states that the role of melatonin as an antidepressant has yet to be demonstrated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.